Johnson & Johnson (JNJ) Reports Strong Q3 2023 Results with Notable Sales and EPS Growth

Company increases full-year guidance for sales and adjusted EPS

Related Keywords

,Trueref Technology ,Interventional Solutions ,Consumer Health ,Innovative Medicine ,General Surgery ,Johnson ,Sales Growth ,Reported Sales ,Nyse Jnj ,Arnings Per Share ,